Skip to main content

Vocal Biomarker Market: Virtual Private Assistants Enabling Voice-based Emotion Detection

 Demand for vocal biomarkers is primarily driven by mounting incidences of neurological, psychological, and various other ailments that impact speech such as Parkinson’s disease, depression, and attention deficit & disruptive behavior disorders. According to WHO, nearly 350 Mn individuals across the globe suffered from depression in 2016. The Parkinson’s disease Foundation’s estimates slated nearly 10 Mn patients with the disease worldwide in 2016. High prevalence of these disorders are expected to significantly rub off on demand and sales of vocal biomarkers.
Quantification and detection of imperceptible characteristics and subtle changes in the voice can precisely decipher essential aspects of a person’s changing health, including depression, stress and cardiovascular diseases. Accordingly, clinical psychologists and psychoanalysts have been using vocal patterns of patients to assess their personality traits and move further in leaps and bounds in medical and clinical investigations.
Get Free Sample Report Here:
https://www.factmr.com/connectus/sample?flag=S&rep_id=719
A recently compiled report of Fact.MR envisages the global vocal biomarker market to record a spectacular 23.3% CAGR between the forecast period 2018 and 2027. Revenues from global sales of vocal biomarkers are foreseen to surpass US$ 390 Mn by 2027-end. Beyond Verbal, Sonde Health, IBM Corporation, and other leading participants operating in the global vocal biomarker market have been profiled and analyzed in detail in the report.
An Israeli company, Beyond Verbal is developing much anticipated voice-enabled AI solutions, aimed at creating proprietary vocal biomarkers for relentless remote monitoring and personalized healthcare screening of health and emotions. Beyond Verbal infers that clinical data delineated with the help of AI, deep learning and machine learning techniques can assist in predicting and monitoring chronic diseases with initial successful results in alluding the presence of sleep apnea, COPD, CHF and detecting coronary artery disease through the voice. Another pertinent company, Sonde Health Inc. joined hands with Massachusetts Institute of Technology (MIT) to introduce voice-based technology platform, enabling diagnosis and monitoring of various conditions and diseases.
Embracing the future by leveraging technology, psychiatrists or psychologists could use biomarkers to instantaneously diagnose postpartum depression in new mothers, PTSD, specific cancers, Parkinson’s disease and even senile dementia.
Leveraging Product Development to Enhance Collaboration
Product development prevails as an imperative strategy driving collaborating between leading companies and research institutes across various sectors, and healthcare is no exception, Apropos of vocal biomarkers, Beyond Verbal has developed “Beyond mHealth Research Platform”, which aims at collaborating with universities, businesses, hospitals, and research institutes for collectively developing unique vocal biomarkers.
Vocal Biomarker Market: Overview
The report offers an up-to-date and comprehensive analysis on vocal biomarker market taking qualitative and quantitative assessment into consideration. The report also elucidates the dynamics of the market such as drivers, restraints, trend and opportunities which have significant impact in the growth of the market. The report peruses into the segregation of market to present a holistic picture of vocal biomarker.
Browse Full Report with ToC Here: 
https://www.factmr.com/report/719/vocal-biomarker-market
The report encompasses comprehensive executive summary along with market overview section. The report also delineates economic outlook and profitability of enterprises. The report depicts investment feasibility matrix and PEST analysis to offer an in-depth view of the vocal biomarker landscape. The report also includes competition footprint matrix and product life cycle analysis. The report also incorporates mergers and acquisitions in the vocal biomarker market.
The information in the report is backed up by primary research, incorporating interactions in person, a reliable and authentic views of seasoned analyst, surveys, interviews and actionable insights of experts. Besides, the report is underpinned by secondary research encompassing resourceful database, trade journals and verified paid sources. The report is furthered by absolute dollar opportunity analysis which is an instrumental aspect in determining the growth of the vocal biomarker market.
Vocal Biomarker Market: Competitive Scenario
The report also includes Porters’ Five Force Analysis which serves as basis for delineating competitive landscape of vocal biomarker market. Assessing competitiveness becomes imperative to comprehend and anticipate the moves by competitors, for instance. The report includes deep dive analysis with a dashboard view, including product portfolio, financial overview, recent developments and strategies.

Comments

Popular posts from this blog

Electrosurgery Devices Market: Radiofrequency Electrosurgery Devices will Remain the Top-Selling Product

On the back of rising ageing population, increased instances of surgical procedures and technological innovations, the market for electrosurgical devices is likely to slate lucrative growth triggers in the coming years. Significant spike in surgical procedures pertaining neurology, cardiology, gynecology, and several other general surgeries, electrosurgery devices market is in the cusp of exponential growth. Owing to technological innovations the electrosurgery market in North America has demonstrated growth traction over the years. However, increased healthcare spending towards minimally invasive treatment in Asia-Pacific region is expected to propel the market forward, thus contributing as one of the fastest regional hub in electrosurgery devices market. However, factors such as significant product recalls owing to incompliance with FDA framework remain potential challenges for the growth trajectory. Get sample of this report at https://www.factmr.com/connectus/sample?flag=S...

North America to Maintain its Leader Status for the Dermatology Devices Market

 Increasing geriatric population across the world have propelled the demand for the dermatology devices, which in turn has contributed to the growth of the dermatology devices market. Rising adoption of dermatology devices in parallel to the rapid adoption of technology in the dermatology clinics and hospitals for treating skin disorders have been prominent factors for the growth of dermatology devices market. Spur in the spending capability of consumers have facilitated the access to these devices. Pervasiveness of skin disorders has been rising at the global level, which has created demand for acute treatment devices. Developments in the treatment methodologies such as liposuction devices and laser instruments have been successful in attracting the attention of the consumers. A recent report published by Fact.MR states that the global dermatology devices market is anticipated to surpass the whopping value of US$ 1,000 Mn by 2022. Browse Full Report with TOC 'https://www.factm...

Lithotripsy Devices Market: Non-Invasive ESWL Witnessing Immense Traction

The report offers a crisp overview of the lithotripsy devices market, which includes an introduction to the lithotripsy devices market in tandem with a definition of the target product – lithotripsy devices. A systematic breakdown of the lithotripsy devices market has been offered in this chapter, which implies scope of the research involved. Size of lithotripsy devices market has been studied in terms of volume (tons) and value (MN), and forecast on the lithotripsy devices market has been offered for the period between 2018 and 2026. The lithotripsy devices market is projected to continue its steady growth due to the burgeoning cases of kidney stones, coupled with the surging demand for minimally invasive medical treatments. According to Fact.MR report, the  lithotripsy devices market  is anticipated to accelerate at 4.3% CAGR during 2018-2026 to reach a value of US$ 1,095.2 MN by the end of 2026. In recent past, lithotripsy has become the most pref...